The daily chart analysis signals strong bullish momentum in Dr Reddy’s Laboratories, indicating the stock is in an advancing phase. The current wave structure shows Navy Blue Wave 1 progressing within the broader Gray Wave 3, following the end of Gray Wave 2’s corrective movement.

This setup marks the beginning of a potentially powerful upward phase. The impulsive characteristics suggest firm buying interest. As long as the price stays above 1018, the bullish count remains valid. A break below this level may require a technical reassessment.

This configuration provides a strategic overview for investors. With Navy Blue Wave 1 unfolding, there is potential for continued gains. The next likely phase will be the continued rise within Gray Wave 3. Traders should closely monitor for confirmation signals while staying alert to any invalidation that may affect strategy.

Elliott Wave technical analysis

Function: Bullish Trend

Mode: Impulsive

Structure: Navy Blue Wave 1

Position: Gray Wave 3

Direction next lower degrees: Navy Blue Wave 2

Details: Gray Wave 2 appears completed; Navy Blue Wave 1 of Gray Wave 3 is active.

Wave cancel invalid level: 1018.

The weekly chart presents a robust bullish outlook for Dr Reddy’s Laboratories, highlighting a strong impulsive move. The current pattern shows Navy Blue Wave 1 progressing within Gray Wave 3, confirming the completion of the earlier corrective phase in Gray Wave 2.

This setup indicates the beginning of a potentially extended upward trajectory. Institutional buying appears to support the move. The structure holds unless price falls below 1018, which would invalidate the count and suggest reevaluation.

For long-term investors, this chart provides essential insights. The next wave expected is Navy Blue Wave 2, which would follow the completion of the current impulsive advance. Continued monitoring of price and support levels is recommended.

Dr Reddy Laboratories – DRREDDY Elliott Wave technical analysis [Video]

Author

Peter Mathers

TradingLounge

Peter Mathers started actively trading in 1982. He began his career at Hoei and Shoin, a Japanese futures trading company.

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

Editor's Picks

EUR/USD: Bulls pray for a dovish Fed

EUR/USD has finally taken a breather after a pretty energetic climb. The pair broke above 1.1680 in the second half of the week, reaching its highest levels in around two months before running into some selling pressure. Even so, it has gained almost two cents from the late-November dip just below 1.1500 the figure.

GBP/USD trims gains, recedes toward 1.3320

GBP/USD is struggling to keep its daily advance, coming under fresh pressure and retreating to the 1.3320 zone following a mild bullish attempt in the Greenback. Even though US consumer sentiment surprised to the upside, the US Dollar isn’t getting much love, as traders are far more interested in what the Fed will say next week.

Gold: Bullish momentum fades despite broad USD weakness

After rising more than 3.5% in the previous week, Gold has entered a consolidation phase and fluctuated at around $4,200. The Federal Reserve’s interest rate decision and revised Summary of Economic Projections, also known as the dot plot, could trigger the next directional move in XAU/USD.

Week ahead: Rate cut or market shock? The Fed decides

Fed rate cut widely expected; dot plot and overall meeting rhetoric also matter. Risk appetite is supported by Fed rate cut expectations; cryptos show signs of life. RBA, BoC and SNB also meet; chances of surprises are relatively low. Dollar weakness could linger; both the aussie and the yen best positioned to gain further. Gold and oil eye Ukraine-Russia developments; a peace deal remains elusive.

Week ahead – Rate cut or market shock? The Fed decides

Ripple faces persistent bear risks, shrugging off ETF inflows

Ripple is extending its decline for the second consecutive day, trading at $2.06 at the time of writing on Friday. Sentiment surrounding the cross-border remittance token continues to lag despite steady inflows into XRP spot ETFs.